Compare Novavax Inc (NVAX) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Zoom Video Communications, Inc. — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Zoom Video Communications, Inc. trades at $89.57 (market cap $26.66B). The key difference: Zoom Video Communications, Inc. is far larger — about 20.5× Novavax Inc's market cap. Which is the better fit depends on your goals.
| NVAX | ZM | |
|---|---|---|
Market Cap | $1.30B | $26.66B |
Sector | Health | Technology |
52-Week High | $11.19 | $111.88 |
52-Week Low | $6.22 | $69.77 |
Enterprise Value | $800.50M | $19.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
Zoom Communications (ZM) trades at $89.77, down 1.49% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with 77.4% gross margins and 42% net income margins, while recent AI-focused acquisitions and APAC leadership appointments signal growth initiatives. Q1 2026 earnings beat expectations with $1.55 EPS versus $1.42 expected.
Investment outlook remains positive with a $118.79 consensus price target offering 32% upside potential, though risks include competitive pressure from Microsoft and Google, insider selling activity, and fluctuating cash flow trends. Wall Street sentiment is mixed with 39% buy ratings versus 55% hold recommendations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
